Lily Group Résultats passés
Passé contrôle des critères 4/6
Lily Group's earnings have been declining at an average annual rate of -10.4%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 4.2% per year. Lily Group's return on equity is 8.4%, and it has net margins of 7.8%.
Informations clés
-10.4%
Taux de croissance des bénéfices
-10.7%
Taux de croissance du BPA
Chemicals Croissance de l'industrie | 12.1% |
Taux de croissance des recettes | 4.2% |
Rendement des fonds propres | 8.4% |
Marge nette | 7.8% |
Dernière mise à jour des bénéfices | 30 Sep 2024 |
Mises à jour récentes des performances passées
Recent updates
Market Still Lacking Some Conviction On Lily Group Co., Ltd. (SHSE:603823)
Sep 28More Unpleasant Surprises Could Be In Store For Lily Group Co., Ltd.'s (SHSE:603823) Shares After Tumbling 28%
Jun 19Lily Group (SHSE:603823) Will Want To Turn Around Its Return Trends
May 27Some Investors May Be Willing To Look Past Lily Group's (SHSE:603823) Soft Earnings
May 06After Leaping 25% Lily Group Co., Ltd. (SHSE:603823) Shares Are Not Flying Under The Radar
Apr 07Lily Group (SHSE:603823) Might Be Having Difficulty Using Its Capital Effectively
Feb 27Ventilation des recettes et des dépenses
Comment Lily Group gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
30 Sep 24 | 2,351 | 183 | 121 | 85 |
30 Jun 24 | 2,374 | 166 | 122 | 84 |
31 Mar 24 | 2,321 | 145 | 123 | 82 |
31 Dec 23 | 2,284 | 120 | 130 | 85 |
30 Sep 23 | 2,265 | 108 | 131 | 82 |
30 Jun 23 | 2,212 | 121 | 136 | 92 |
31 Mar 23 | 2,375 | 163 | 138 | 94 |
31 Dec 22 | 2,468 | 215 | 137 | 95 |
30 Sep 22 | 2,562 | 278 | 146 | 93 |
30 Jun 22 | 2,607 | 304 | 142 | 94 |
31 Mar 22 | 2,507 | 304 | 142 | 97 |
31 Dec 21 | 2,457 | 312 | 145 | 94 |
30 Sep 21 | 2,408 | 304 | 139 | 93 |
30 Jun 21 | 2,337 | 314 | 132 | 87 |
31 Mar 21 | 2,213 | 303 | 123 | 84 |
31 Dec 20 | 2,005 | 260 | 116 | 76 |
30 Sep 20 | 1,915 | 229 | 136 | 81 |
30 Jun 20 | 1,876 | 217 | 134 | 80 |
31 Mar 20 | 1,911 | 222 | 140 | 81 |
31 Dec 19 | 1,981 | 227 | 134 | 82 |
30 Sep 19 | 1,944 | 213 | 114 | 79 |
30 Jun 19 | 1,928 | 215 | 117 | 75 |
31 Mar 19 | 1,885 | 190 | 109 | 79 |
31 Dec 18 | 1,813 | 190 | 109 | 76 |
30 Sep 18 | 1,780 | 198 | 108 | 72 |
30 Jun 18 | 1,668 | 163 | 67 | 96 |
31 Mar 18 | 1,539 | 143 | 83 | 70 |
31 Dec 17 | 1,511 | 133 | 87 | 58 |
30 Sep 17 | 1,422 | 113 | 101 | 44 |
30 Jun 17 | 1,416 | 119 | 142 | 0 |
31 Mar 17 | 1,396 | 136 | 134 | 0 |
31 Dec 16 | 1,359 | 140 | 144 | 0 |
30 Sep 16 | 1,307 | 145 | 237 | 0 |
31 Dec 15 | 1,156 | 130 | 131 | 0 |
31 Dec 14 | 1,268 | 118 | 149 | 0 |
31 Dec 13 | 1,180 | 109 | 127 | 0 |
Des revenus de qualité: 603823 has high quality earnings.
Augmentation de la marge bénéficiaire: 603823's current net profit margins (7.8%) are higher than last year (4.8%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: 603823's earnings have declined by 10.4% per year over the past 5 years.
Accélération de la croissance: 603823's earnings growth over the past year (69.5%) exceeds its 5-year average (-10.4% per year).
Bénéfices par rapport au secteur d'activité: 603823 earnings growth over the past year (69.5%) exceeded the Chemicals industry -3.8%.
Rendement des fonds propres
ROE élevé: 603823's Return on Equity (8.4%) is considered low.